BURNABY, British Columbia--(BUSINESS WIRE)-- ARTMS Inc. (ARTMS), the global leader in developing and commercializing novel products enabling cyclotron production of the world’s most needed medical ...
(Alliance News) - Imaging Biometrics Ltd shares fell on Friday, after it said it will no longer proceed with an intended phase 2 trial of gallium maltolate. The stock tumbled 33% to 0.57 pence on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results